Skip to main content
OCUL logo
OCUL
(NASDAQ)
Ocular Therapeutix, Inc.
$10.04-- (--)
Loading... - Market loading

Ocular Therapeutix (OCUL) Stock Price & Financial Analysis

Ocular Therapeutix Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.68 - $10.07
52-Week High$16.44
52-Week Low$6.23
Open$10.04
Volume1.63M
Average Volume (3M)2.13M
Market Cap2.25B
Shares Outstanding224.10M
Price to Sales (P/S)39.58
Price to Book (P/B)3.54
EV/EBITDA-5.37
Revenue (TTM)52.04M
Net Income (TTM)-290.50M
Free Cash Flow (TTM)-240.94M
EPS (TTM)$-1.45
Profit Margin-558.24%
Operating Margin-575.42%
Return on Equity (ROE)-49.95%
Debt to Equity0.14
50-Day MA$9.14
200-Day MA$10.01
52-Week Change-24.73%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Ocular Therapeutix

What is the current stock price for OCUL?

As of the latest trading session, OCUL stock trades at $10.04. The 52-week range is $6.23–$16.44, with a day range of $9.68–$10.07.

What is the P/E ratio for OCUL?

The P/E ratio (Price-to-Earnings) for OCUL is shown in the Key Statistics section. This valuation metric helps compare Ocular Therapeutix, Inc. to industry peers.

Does OCUL pay dividends?

Ocular Therapeutix does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OCUL?

Based on 9 analysts, the consensus for OCUL is Buy.

What is the market cap of OCUL?

Ocular Therapeutix's market capitalization is $2.25B, classifying it as a mid-cap company. Ocular Therapeutix operates in the Healthcare sector within the Biotechnology industry.